Roundup Cancer Trial Ends in Defense Verdict in Missouri Court

The Roundup lawsuit claimed a woman developed non-Hodgkin's lymphoma after exposure to the glyphosate-based weedkiller while gardening

A St. Louis jury has returned a defense verdict in the latest trial alleging that Roundup caused cancer, involving claims that spraying the controversial weedkiller while gardening resulted in non-Hodgkins lymphoma.

The Roundup lawsuit was filed by Sharlean Gordon, and is one of more than 90,000 claims that have been brought against Monsanto in recent years, each involving similar allegations that consumers were not adequately warned about the cancer risks associated use of the widely marketed weedkiller.

After getting hit with a series of massive verdicts in 2018 and 2019, Monsanto has agreed to pay billions in Roundup settlements to resolve individual claims. However, thousands of lawsuits were left unresolved and new claims continue to be filed as former users of Roundup are diagnosed with non-Hodkins lymphoma years later.

Learn More About

Roundup Lawsuits

Exposure to RoundUp May Increase Risk of Non-Hodgkins Lymphoma and Other Cancers. Lawsuits Reviewed Nationwide.

Learn More About this Lawsuit See If You Qualify For Compensation

Gordon was diagnosed with non-Hodgkin’s lymphoma at the age of 39, maintaining at trial that her diagnosis was directly caused by exposure to the chemicals in Roundup, pointing to a series of studies and evidence uncovered in recent years that glyphosate increases the risk of cancer. Gordon indicates she applied Roundup using spray bottles with her stepfather as a child, and sought $36 million in damages.

Following a multi-week trial, a St. Louis County jury returned a defense verdict on Tuesday, determining that Monsanto and its parent company, Bayer, can not be held liable for Gordon’s injuries.

While the outcome of Gordon’s trial will not have any binding impact on other claims, it was being closely watched to help gauge how juries in Missouri may respond to certain evidence and testimony likely to be repeated throughout the litigation.

Most of the remaining cases against Monsanto are currently pending in the state courts of Missouri, where the manufacturer’s U.S. headquarters are located and it remains a major employer. However, additional trials are expected to begin this year in Florida and California state courts.

In addition to the state court litigation, hundreds of claims are currently centralized in the federal court system before U.S. District Judge Vince Chhabria in the Northern District of California, where several large waves of claims are being prepared for remand to different federal district court for trial.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.